 NAPLES, Fla. , Jan. 27, 2022 PRNewswire - Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming investor conferences: Citis Psychedelic Drug Call Series Tuesday, February 8 th at 10:00 a.m. 